Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.68 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.68 |
| ▸ | FAAH | O00519 | 1/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6138404 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL310070 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL155391 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL311217 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL7077603 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL23698920 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL311718 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL1268124 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL7080958 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL8441815 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114874293-B | Cyclic polypeptide compound and preparation method and application thereof | 中国医学科学院医药生物技术研究所 | 2025-05-23 | — | — | CN | disclosed |
| CN-119606879-A | Antipruritic gel containing 3-hydroxydecanoic acid microemulsion and preparation method thereof | 浙江工业大学 | 2025-03-14 | — | — | CN | disclosed |
| CN-112912383-B | Peptide compounds | 优拓制药公司 | 2024-07-05 | — | — | CN | disclosed |
| US-11981755-B2 | Peptide compounds | ULTUPHARMA AB (SE) | 2024-05-14 | — | — | US | disclosed |
| CN-115010749-B | Preparation process of phosphatidic acid | 沈阳金久奇科技有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117882725-A | Biological insecticide, preparation method and application | 湖州紫金生物科技有限公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-115010749-A | Preparation process of phosphatidic acid | 沈阳金久奇科技有限公司 | 2022-09-06 | — | — | CN | disclosed |
| CN-114874293-A | Cyclic polypeptide compounds and preparation method and application thereof | 中国医学科学院医药生物技术研究所 | 2022-08-09 | — | — | CN | disclosed |
| US-20210247400-A1 | ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF | Technische Universität München (DE) | 2021-08-12 | — | — | US | disclosed |
| US-20210247400-A1 | ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF | Technische Universität München (DE) | 2021-08-12 | — | — | US | disclosed |
| US-20070265451-A1 | Process for the preparation of oxazolidinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2007-11-15 | — | — | US | disclosed |
| EP-1578723-A4 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | UNIV MICHIGAN STATE (US) | 2006-11-02 | — | — | EP | disclosed |
| EP-1578723-A3 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2005-10-20 | — | — | EP | disclosed |
| EP-1578723-A2 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2005-09-28 | — | — | EP | disclosed |
| EP-0920852-B1 | Keratin fiber strengthening agent and method for strengthening keratin fiber | TAKASAGO PERFUMERY CO LTD (JP) | 2005-06-01 | — | — | EP | disclosed |
| WO-2003106413-A2 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2003-12-24 | — | — | WO | disclosed |
| US-6379659-B1 | APPLYING (2S,3R)-2-ACYLAMINOALKANE-1,3-DIOL TO FIBER | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-04-30 | — | — | US | disclosed |
| EP-0920852-A2 | Keratin fiber strengthening agent and method for strengthening keratin fiber | Takasago International Corporation (JP) | 1999-06-09 | — | — | EP | disclosed |
| EP-0393883-A1 | Novel cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1990-10-24 | — | — | EP | disclosed |
| US-4948791-A | ANTITUMOR AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1990-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265451-A1 | Process for the preparation of oxazolidinones and method of use thereof | OXA1L, OTC, ODC1 | GPR84 4516/4885FFAR1 4712/4885FFAR4 4180/4885 |
| US-11981755-B2 | Peptide compounds | VIP, NGLY1, TLR5 | GPR84 288/4885FFAR1 951/4885FFAR4 755/4885 |
| US-20210247400-A1 | ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF | PGLS, LIPE, LYPLA2 | GPR84 2281/4885FFAR1 1534/4885FFAR4 1015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.